Inventor · disambiguated record
Marc Gerspacher
Also filed as: GERSPACHER MARC
17 granted patents·8 pending applications·68 citations·filing 1992–2022
91Inventor score
Top patents by PatentIndex Score
25 records- 0179US6319917B1Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonistsNOVARTIS AG·Filed 2000·Granted Nov 20, 2001·14 cites·14 claims
- 0274US8629168B2Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitorsGERSPACHER MARC·Filed 2007·Granted Jan 14, 2014·3 cites·11 claims
- 0372US8293753B2Substituted 2-carboxamide cycloamino ureasFAIRHURST ROBIN ALEC·Filed 2010·Granted Oct 23, 2012·2 cites·4 claims
- 0472US8193189B2Quinoxaline derivatives as tyrosine kinase activity inhibitorsGERSPACHER MARC·Filed 2008·Granted Jun 5, 2012·3 cites·10 claims
- 0564US7696216B2Aryl-quinazoline/aryl-2-amino-phenyl methanone derivativesNOVARTIS AG·Filed 2003·Granted Apr 13, 2010·2 cites·15 claims
- 0663US8420657B2Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitorsGAUL CHRISTOPH·Filed 2009·Granted Apr 16, 2013·1 cites·8 claims
- 0763US5248693AAcetylene compounds and pharmaceutical compositions and methods of using the sameCIBA GEIGY CORP·Filed 1992·Granted Sep 28, 1993·16 cites·16 claims
- 0859US2024317721A1Pyrazolyl derivatives as inhibitors of the kras mutant proteinNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0957US8569317B2Aryl-quinazoline/aryl-2amino-phenyl methanone derivativesALTMANN EVA·Filed 2009·Granted Oct 29, 2013·0 cites·3 claims
- 1056US2024366567A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses thereof for the treatment of cancersNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1154US5604247AChromone DerivativesCIBA GEIGY CORP·Filed 1996·Granted Feb 18, 1997·11 cites·10 claims
- 1253US2024082218A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1352US12226405B2Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of useNOVARTIS AG·Filed 2021·Granted Feb 18, 2025·0 cites·30 claims
- 1451US5929067A1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonistsNOVARTIS AG·Filed 1996·Granted Jul 27, 1999·9 cites·10 claims
- 1551US2024116900A1New crystalline forms of a kras g12c inhibitor compoundNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1650US11702409B2Pyrazolyl derivatives useful as anti-cancer agentsNOVARTIS AG·Filed 2020·Granted Jul 18, 2023·0 cites·34 claims
- 1745US5508408AQuinoline compoundCIBA GEIGY CORP·Filed 1994·Granted Apr 16, 1996·6 cites·13 claims
- 1843US2010227889A1Benzimidazole DerivativesGERSPACHER MARC·Filed 2007·Application pending·0 cites
- 1941US8030497B2Benzimidazole derivativesNOVARTIS AG·Filed 2005·Granted Oct 4, 2011·0 cites·4 claims
- 2040US2010010025A1Pyrimidine DerivativesNORVARTIS AG·Filed 2007·Application pending·0 cites
- 2138US8357707B22-carboxamide cycloamino ureasNOVARTIS AG·Filed 2010·Granted Jan 22, 2013·0 cites·11 claims
- 2237US2014329858A1Cyclic Urea Derivatives As Androgen Receptor AntagonistsBOCK MARK GARY·Filed 2012·Application pending·0 cites
- 2334US2010222396A14-aryl-butane-1,3-diamidesNOVARTIS AG·Filed 2010·Application pending·0 cites
- 2431US5359083AProcess for the preparation of substituted indolesCIBA GEIGY CORP·Filed 1994·Granted Oct 25, 1994·0 cites·7 claims
- 2529US5399714AProcess for the preparation of substituted indolesCIBA GEIGY CORP·Filed 1994·Granted Mar 21, 1995·1 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →